ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

Patch-Lozenge Combination Best For Smoking Cessation

November 27, 2009

Rep. Regula To Lead House Labor, HHS; Specter Likely Senate Labor, HHS Chairman.

January 12, 2001

OMB Ploy Would Delay Funding 1,500 NIH Grants From FY 1985 To 1986; Other Cuts Are Considered

January 18, 1985

NCAB Approves Plan for Public Participation Hearings Around U.S.

February 20, 1987